Trying new brain stimulation to help ADHD symptoms

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This open-label study will apply theta burst rTMS to the right prefrontal cortex over four weeks (five sessions per week) to see if ADHD symptoms improve. Participants will undergo baseline MRI and neuropsychological assessments, receive the brain stimulation, then have post-intervention testing and MRI. The goal is to determine whether non-invasive brain stimulation can produce measurable improvements in attention and related behaviors for youths with ADHD. Results will inform feasibility and potential signal of benefit in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Diagnosis of ADHD
2. 9-15 years old
3. IQ greater than 80
4. English fluency (to enable consent/assent)
5. If on medication, must have been on the same type and dosage for at least 3 months.

Exclusion Criteria:

1. Diagnosis of mania, psychosis, or bipolar disorder
2. Impediments to TMS or MRI (i.e. metal implants in body)
3. Prior electroconvulsive therapy or vagus nerve stimulation
4. Diagnosis of Autism Spectrum Disorder.

Where it's running

• Alberta Children's Hospital
  Calgary, Alberta, Canada Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Binaural Beats for Adults with ADHD

  We’re testing whether a six-week program of music with embedded binaural beats helps adults with ADHD, compared to similar music without binaural beats.

  Recruiting California State University, San Bernardino · San Bernardino, California · NCT07793045

• Cannabigerol Oil for Adolescents With ADHD

  This study tests full-spectrum cannabigerol (CBG) oil to see if it helps kids aged 12–17 who have ADHD and haven’t fully benefited from other treatments.

  Recruiting Phase 1/2 Universidade do Sul de Santa Catarina · Tubarão, Santa Catarina · NCT07592390

• OutSMARTers program for kids with ADHD ages 9–12

  This trial tests whether a group skills program called OutSMARTers helps 9–12 year-olds with ADHD compare to five weeks of individual counseling to see which improves communication, well-being, and emotional regulation.

  Recruiting University of Iceland · Reykjavik · NCT07379359

• Treating ADHD in preschoolers: methylphenidate vs guanfacine

  This study tests whether methylphenidate or guanfacine works better for kids ages 3–5 with ADHD.

  Recruiting at 5 sites Phase 4 Children's Hospital Medical Center, Cincinnati · Palo Alto, California and 4 other locations · NCT07300956

• Methylphenidate for attention and executive problems in children with sickle cell disease

  This study will test whether once-daily extended-release methylphenidate for 4 weeks helps attention and thinking skills in children 8–17 with sickle cell disease while monitoring side effects and adherence.

  Recruiting Phase 1 St. Jude Children's Research Hospital · Memphis, Tennessee · NCT07226219

• Trying two forms of dexamfetamine sulfate for adults with ADHD and moderate-to-severe depression

  This tests whether immediate-release and extended-release dexamfetamine sulfate can improve attention and depressive symptoms in adults with ADHD and moderate-to-severe major depression compared with placebo.

  Recruiting at 5 sites Phase 2 Fraunhofer Institute for Translational Medicine and Pharmacology ITMP · Berlin and 4 other locations · NCT06967857

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.